Kelly Davio | Authors


Avapritinib Could Deliver Precision Medicine to Patients With GIST, Says Heinrich

November 17, 2018

The investigational agent avapritinib demonstrated encouraging response rates in patients with advanced gastrointestinal stromal tumors and PDGFRα D842V-driven GIST, according to findings presented during the 2018 Annual Meeting of the Connective Tissue Oncology Society in Rome, Italy.

Crizotinib Holds Promise for Treating IMFT, Says Schoffski

November 15, 2018

Patrick Schöffski, MD, MPH, discussed the key findings from the CREATE trial, the next steps for research into inflammatory myofibroblastic tumor, and the regulatory challenges for approval of drugs for rare cancers.

Expert Stresses Importance of Cultivating Tailored Treatment in HCC

September 14, 2018

Fabio Piscaglia, MD, discusses the updated 2018 European Association for the Study of the Liver clinical guidelines, which were presented during the 12th International Liver Cancer Association Annual Conference in London, United Kingdom.